HIT Consultant March 14, 2024
What You Should Know:
– Tempus, a leader in artificial intelligence and precision medicine, announced a groundbreaking data contribution to the National Cancer Institute (NCI) today.
– The first-of-its-kind contribution will significantly enhance the NCI’s planned Data Enclave, a secure repository designed to accelerate cancer research.
Unlocking Insights from 3,000 Cancer Diagnoses
Tempus is donating de-identified tumor profiles with limited associated clinical information from over 3,000 cancer diagnoses. These anonymized data sets, derived from patients sequenced with Tempus’ xT assay, will build upon the foundation established by The Cancer Genome Atlas (TCGA) sequencing project.
Empowering Researchers with Secure Data Access
Researchers will be able to securely access and query this valuable data through the NCI Data Enclave. This innovative system...
Today's Sponsors
Today's Sponsor